Cargando…
Plasma Metabolomics Identifies Lipid and Amino Acid Markers of Weight Loss in Patients with Upper Gastrointestinal Cancer
Cachexia is a multifactorial wasting syndrome associated with high morbidity and mortality in patients with cancer. Diagnosis can be difficult and, in the clinical situation, usually relies upon reported weight loss. The ‘omics’ technologies allow us the opportunity to study the end points of many b...
Autores principales: | Miller, Janice, Alshehri, Ahmed, Ramage, Michael I., Stephens, Nathan A., Mullen, Alexander B., Boyd, Marie, Ross, James A., Wigmore, Stephen J., Watson, David G., Skipworth, Richard J.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826420/ https://www.ncbi.nlm.nih.gov/pubmed/31635032 http://dx.doi.org/10.3390/cancers11101594 |
Ejemplares similares
-
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers
por: Brown, Leo R., et al.
Publicado: (2022) -
Adipose depot gene expression and intelectin‐1 in the metabolic response to cancer and cachexia
por: Miller, Janice, et al.
Publicado: (2020) -
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
por: Stephens, Nathan A, et al.
Publicado: (2015) -
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers
por: Husi, Holger, et al.
Publicado: (2019) -
Neuromuscular junctions are stable in patients with cancer cachexia
por: Boehm, Ines, et al.
Publicado: (2020)